Metachronous lung cancer in a patient after successfully treated small cell lung cancer
Ahmet BAŞOĞLU,1 Ayşen TASLAK ŞENGÜL,1 İlkser AKPOLAT,2 Nilgün ÖZBEK,3 İdris YÜCEL4
1Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Göğüs Cerrahisi Anabilim Dalı, Samsun
2Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Patoloji Anabilim Dalı, Samsun
3Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisi Anabilim Dalı, Samsun
4Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Medikal Onkoloji Anabilim Dalı, Samsun
It is known that the risk of developing a second primary respiratory or digestive tract tumor is high in treated small cell lung cancers. This study aimed to present a patient with metachronous small cell and non-small cell lung cancer. Thirteen years before, the 78-year-old male patient received chemotherapy and radiotherapy due to limited-stage small cell cancer in the right lung. In the 6th year of the follow-up, he underwent right upper lobectomy due to lung epidermoid carcinoma, stage 2B. Over the 7 years following lobectomy, he had been followed without any problems. In small cell lung cancer patients with a survival of more than 2 years, the risk of developing a second primary non-small cell lung cancer is 7-16 times higher compared to those who smoke but do not have cancer. Patients should be followed closely so that a possible metachronous tumor can be detected in the early stages. Keywords : Small cell lung cancer; cure; metachronous